Charles M. Paden

1.4k total citations
38 papers, 1.2k citations indexed

About

Charles M. Paden is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Social Psychology. According to data from OpenAlex, Charles M. Paden has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cellular and Molecular Neuroscience, 13 papers in Molecular Biology and 12 papers in Social Psychology. Recurrent topics in Charles M. Paden's work include Neuroendocrine regulation and behavior (12 papers), Neuroscience and Neuropharmacology Research (8 papers) and Receptor Mechanisms and Signaling (6 papers). Charles M. Paden is often cited by papers focused on Neuroendocrine regulation and behavior (12 papers), Neuroscience and Neuropharmacology Research (8 papers) and Receptor Mechanisms and Signaling (6 papers). Charles M. Paden collaborates with scholars based in United States, Sweden and Israel. Charles M. Paden's co-authors include Ann‐Judith Silverman, Joan W. Witkin, Anat Biegon, John A. Watt, Alexander Alexandrovich, Jeanna Tsenter, Victoria N. Luine, Esther Shohami, Bruce S. McEwen and Wesley C. Lynch and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and The Journal of Comparative Neurology.

In The Last Decade

Charles M. Paden

37 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles M. Paden United States 17 478 316 299 278 184 38 1.2k
Suzanne Numan United States 12 471 1.0× 110 0.3× 212 0.7× 212 0.8× 171 0.9× 12 1.0k
Caleb E. Finch United States 14 343 0.7× 218 0.7× 243 0.8× 101 0.4× 207 1.1× 18 1.2k
Frank Baldino United States 25 922 1.9× 189 0.6× 612 2.0× 462 1.7× 321 1.7× 41 1.8k
Andrea E. Kudwa United States 16 461 1.0× 318 1.0× 418 1.4× 311 1.1× 290 1.6× 24 1.3k
Jun Arita Japan 26 459 1.0× 361 1.1× 443 1.5× 327 1.2× 302 1.6× 91 1.7k
Joan A. Sim United Kingdom 18 325 0.7× 501 1.6× 372 1.2× 275 1.0× 78 0.4× 21 1.5k
Franco Sánchez‐Franco Spain 25 374 0.8× 192 0.6× 391 1.3× 140 0.5× 130 0.7× 72 1.5k
Bruce E. Maley United States 24 869 1.8× 168 0.5× 452 1.5× 228 0.8× 93 0.5× 47 1.6k
Istvàn Lengvári Hungary 26 1.2k 2.6× 177 0.6× 705 2.4× 249 0.9× 144 0.8× 68 1.9k
Stephen J. Bunn Australia 24 521 1.1× 271 0.9× 616 2.1× 351 1.3× 201 1.1× 67 1.6k

Countries citing papers authored by Charles M. Paden

Since Specialization
Citations

This map shows the geographic impact of Charles M. Paden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles M. Paden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles M. Paden more than expected).

Fields of papers citing papers by Charles M. Paden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles M. Paden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles M. Paden. The network helps show where Charles M. Paden may publish in the future.

Co-authorship network of co-authors of Charles M. Paden

This figure shows the co-authorship network connecting the top 25 collaborators of Charles M. Paden. A scholar is included among the top collaborators of Charles M. Paden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles M. Paden. Charles M. Paden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grossman, Rachel, et al.. (2012). Persistent Region-Dependent Neuroinflammation, Nmda Receptor Loss and Atrophy In An Animal Model of Penetrating Brain Injury. Future Neurology. 7(3). 329–339. 13 indexed citations
2.
Watt, John A., et al.. (2008). CNTF receptor alpha is expressed by magnocellular neurons and expression is upregulated in the rat supraoptic nucleus during axonal sprouting. Experimental Neurology. 215(1). 135–141. 7 indexed citations
3.
Babcock, Alex M., et al.. (2005). In vivo Inhibition of Hippocampal Ca2+/Calmodulin-Dependent Protein Kinase II by RNA Interference. Molecular Therapy. 11(6). 899–905. 23 indexed citations
4.
Paden, Charles M., et al.. (2005). The Neuronal Growth-Associated Protein (GAP)-43 Is Expressed by Corticotrophs in the Rat Anterior Pituitary After Adrenalectomy. Endocrinology. 147(2). 952–958. 7 indexed citations
5.
Mueller, Nancy K., Shi Di, Charles M. Paden, & James P. Herman. (2004). Activity-Dependent Modulation of Neurotransmitter Innervation to Vasopressin Neurons of the Supraoptic Nucleus. Endocrinology. 146(1). 348–354. 17 indexed citations
6.
Babcock, Alex M., et al.. (2002). Baclofen is neuroprotective and prevents loss of calcium/calmodulin‐dependent protein kinase II immunoreactivity in the ischemic gerbil hippocampus. Journal of Neuroscience Research. 67(6). 804–811. 30 indexed citations
7.
Watt, John A. & Charles M. Paden. (2001). Upregulation of the p75 low-affinity neurotrophin receptor by phagocytically active perivascular cells in the rat neural lobe. Cell and Tissue Research. 303(1). 81–91. 9 indexed citations
8.
Babcock, Alex M., Hui Liu, Charles M. Paden, Severn B. Churn, & Andrew J. Pittman. (1999). In vivo glutamate neurotoxicity is associated with reductions in calcium/calmodulin-dependent protein kinase II immunoreactivity. Journal of Neuroscience Research. 56(1). 36–43. 8 indexed citations
9.
Zhou, Xinrong, James P. Herman, & Charles M. Paden. (1999). Evidence That IGF-I Acts as an Autocrine/Paracrine Growth Factor in the Magnocellular Neurosecretory System: Neuronal Synthesis and Induction of Axonal Sprouting. Experimental Neurology. 159(2). 419–432. 18 indexed citations
10.
Zhou, Xinrong, James P. Herman, & Charles M. Paden. (1997). Expression of Insulin-Like Growth Factor Binding Protein-2 during Postnatal Development of the Rat Neurointermediate Pituitary. Neuroendocrinology. 66(1). 17–27. 7 indexed citations
11.
12.
Paden, Charles M., et al.. (1994). Microglia in the rat neurohypophysis increase expression of class I major histocompatibility antigens following central nervous system injury. Journal of Neuroimmunology. 50(2). 139–151. 27 indexed citations
13.
Paden, Charles M., et al.. (1993). Differential Distributions of Novel Antigens within Vasopressin Dense Core Vesicles Revealed by Monoclonal Antibodiesa. Annals of the New York Academy of Sciences. 689(1). 649–650. 1 indexed citations
14.
Paden, Charles M., et al.. (1992). Expression of a novel nuclear protein is correlated with neuronal differentiation in vivo. Journal of Neurobiology. 23(3). 231–251. 1 indexed citations
15.
Watt, John A. & Charles M. Paden. (1991). Compensatory sprouting of uninjured magnocellular neurosecretory axons in the rat neural lobe following unilateral hypothalamic lesion. Experimental Neurology. 111(1). 9–24. 16 indexed citations
16.
Paden, Charles M., et al.. (1991). Monoclonal antibodies identify two novel proteins associated with vasopressin secretory granules of the rat neurohypophysis. Brain Research. 545(1-2). 151–163. 3 indexed citations
17.
Paden, Charles M., et al.. (1987). Heterogeneous distribution and upregulation of μ, δ and κ opioid receptors in the amygdala. Brain Research. 418(2). 349–355. 34 indexed citations
18.
Luine, Victoria N. & Charles M. Paden. (1982). Effects of Monoamine Oxidase Inhibition on Female Sexual Behavior, Serotonin Levels and Type A and B Monoamine Oxidase Activity. Neuroendocrinology. 34(4). 245–251. 34 indexed citations
19.
20.
Paden, Charles M., Charles J. Wilson, & Philip M. Groves. (1976). Amphetamine-induced release of dopamine from the substantia nigra. Life Sciences. 19(10). 1499–1506. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suzanne Numan Breakdown of academic impact, for papers by Caleb E. Finch Breakdown of academic impact, for papers by Frank Baldino Breakdown of academic impact, for papers by Andrea E. Kudwa Breakdown of academic impact, for papers by Jun Arita Breakdown of academic impact, for papers by Joan A. Sim Breakdown of academic impact, for papers by Franco Sánchez‐Franco Breakdown of academic impact, for papers by Bruce E. Maley Breakdown of academic impact, for papers by Istvàn Lengvári Breakdown of academic impact, for papers by Stephen J. Bunn
Rankless by CCL
2026